“…The main clinical predictors of fg-SRL resistance recognized in the literature include: male sex [5,13,14], young age [5,[13][14][15][16][17] and tumor hyperintensity on T2-weighted magnetic resonance imaging (MRI) scans [1,7,13,15,16]; however, IGF-I and r-GH values at diagnosis also deserve to be taken into consideration [5,8,[13][14][15][16][17]. Furthermore, the most relevant histological and molecular characteristics identified so far are the following: the grade of expression of the type 2 somatostatin receptors (SSTR2) [1,7,8,15,18], the pathological classification based on cytoplasmic granulation and keratin pattern analyzed by the CAM5.2 antibody [1,7,8,15], the proliferation index Ki-67 [7,18,19] and the presence of aryl hydrocarbon receptor-interacting protein (AIP) gene mutation [8,20,21].…”